2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$16.94+$1.12 (+7.07%)
Price as of Jun 03, 2026 5:57 PM EDT- $1.9BMarket Cap
- -7.16%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$16.94+$1.12 (+7.07%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.82 | ||
Change | -$0.74 (-4.47%) | ||
Open | $16.48 | ||
High | $16.48 | ||
Low | $15.65 | ||
Previous Close | $16.56 | ||
Volume | 1,390,345 | ||
30-Day Average Volume | 1,604,285 | ||
1-Week Change | -13.36% | ||
1-Month Change | -4.81% | ||
1-Year Change | -7.16% | ||
3-Year Change | -80.11% | ||
5-Year Change | -92.25% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $787.9M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $174.1M | ||
Net Income | -$71.1M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$67.4M | ||
EBITDA | -$63.3M | ||
Net Working Capital | $414.1M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 6 | ||
P/E | -27 | ||
PEG | 0 | ||
Price/Free Cash Flow | -102 | ||
Price/Operating Cash Flow | -141 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue